[go: up one dir, main page]

EA202192092A3 - TETRAHYDRO-PYRIDO[3,4-B]INDOL MODULATORS OF ESTROGEN RECEPTORS AND THEIR APPLICATION - Google Patents

TETRAHYDRO-PYRIDO[3,4-B]INDOL MODULATORS OF ESTROGEN RECEPTORS AND THEIR APPLICATION

Info

Publication number
EA202192092A3
EA202192092A3 EA202192092A EA202192092A EA202192092A3 EA 202192092 A3 EA202192092 A3 EA 202192092A3 EA 202192092 A EA202192092 A EA 202192092A EA 202192092 A EA202192092 A EA 202192092A EA 202192092 A3 EA202192092 A3 EA 202192092A3
Authority
EA
Eurasian Patent Office
Prior art keywords
indol
pyrido
tetrahydro
modulators
estrogen receptors
Prior art date
Application number
EA202192092A
Other languages
Russian (ru)
Other versions
EA202192092A2 (en
Inventor
Саймон Чарльз Гудакр
Шарада Лабади
Цзюнь Лян
Даниэль Фред Ортвайн
Николас Чарльз Рэй
Сяоцзин Ван
Джейсон Збиг
Бижун Чжан
Томми Лай
Цзянпэн Ляо
Чжиго Лю
Джон Вай
Тао Ван
Original Assignee
Ф. Хоффманн-Ля Рош Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ф. Хоффманн-Ля Рош Аг filed Critical Ф. Хоффманн-Ля Рош Аг
Publication of EA202192092A2 publication Critical patent/EA202192092A2/en
Publication of EA202192092A3 publication Critical patent/EA202192092A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

В изобретении описаны соединения тетрагидропиридо[3,4-b]индол-1-ила с модулирующей активностью или функцией рецептора эстрогена, имеющие структуру формулы Iа также их стереоизомеры, таутомеры или фармацевтически приемлемые соли, и с заместителями и структурными особенностями, описанными в данном документе. Также описаны фармацевтические композиции и лекарственные препараты, которые включают соединения формулы I, а также способы применения таких модуляторов эстрогеновых рецепторов отдельно и в сочетании с другими терапевтическими агентами для лечения заболеваний или состояний, опосредованных или зависимых от эстрогеновых рецепторов.The invention describes compounds of tetrahydropyrido[3,4-b]indol-1-yl with modulating activity or function of the estrogen receptor, having the structure of formula I and their stereoisomers, tautomers or pharmaceutically acceptable salts, and with substituents and structural features described in this document . Also described are pharmaceutical compositions and medicaments that include compounds of formula I, as well as methods of using such estrogen receptor modulators alone and in combination with other therapeutic agents for the treatment of diseases or conditions mediated or dependent on estrogen receptors.

EA202192092A 2015-04-02 2015-12-17 TETRAHYDRO-PYRIDO[3,4-B]INDOL MODULATORS OF ESTROGEN RECEPTORS AND THEIR APPLICATION EA202192092A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562142077P 2015-04-02 2015-04-02

Publications (2)

Publication Number Publication Date
EA202192092A2 EA202192092A2 (en) 2021-11-30
EA202192092A3 true EA202192092A3 (en) 2022-03-31

Family

ID=66436965

Family Applications (2)

Application Number Title Priority Date Filing Date
EA202192092A EA202192092A3 (en) 2015-04-02 2015-12-17 TETRAHYDRO-PYRIDO[3,4-B]INDOL MODULATORS OF ESTROGEN RECEPTORS AND THEIR APPLICATION
EA201892724A EA038835B1 (en) 2015-04-02 2015-12-17 TETRAHYDRO-PYRIDO[3,4-b]INDOLE ESTROGEN RECEPTOR MODULATORS AND USES THEREOF

Family Applications After (1)

Application Number Title Priority Date Filing Date
EA201892724A EA038835B1 (en) 2015-04-02 2015-12-17 TETRAHYDRO-PYRIDO[3,4-b]INDOLE ESTROGEN RECEPTOR MODULATORS AND USES THEREOF

Country Status (1)

Country Link
EA (2) EA202192092A3 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8076352B2 (en) * 2004-03-15 2011-12-13 Ptc Therapeutics, Inc. Administration of carboline derivatives useful in the treatment of cancer and other diseases
US20120202801A1 (en) * 2009-05-27 2012-08-09 Liangxian Cao Methods for treating breast cancer
US9351964B2 (en) * 2009-05-27 2016-05-31 Ptc Therapeutics, Inc. Methods for treating cancer and non-neoplastic conditions
WO2010138695A1 (en) * 2009-05-27 2010-12-02 Ptc Therapeutics, Inc. Methods for treating neurofibromatosis
CA2857057A1 (en) * 2011-12-14 2013-06-20 Seragon Pharmaceuticals, Inc. Fluorinated estrogen receptor modulators and uses thereof

Also Published As

Publication number Publication date
EA202192092A2 (en) 2021-11-30
EA038835B1 (en) 2021-10-27
EA201892724A1 (en) 2019-04-30

Similar Documents

Publication Publication Date Title
ZA202108745B (en) Tetrahydro-pyrido[3,4-b]indole estrogen receptor modulators and uses thereof
PH12020551315A1 (en) Benzoxazepin oxazolidinone compounds and methods of use
SA518392101B1 (en) Benzimidazole Derivatives as Modulators of ROR-GAMMA
MX375639B (en) SUBSTITUTED HETEROCYCHYL DERIVATIVES AS CDK INHIBITORS
NZ737399A (en) Ccr2 modulators
MX379110B (en) AZASPIRO DERIVATIVES AS TRPM8 ANTAGONISTS.
EA201390821A1 (en) ANTAGONISTS OF LYSOPHPATIDIC ACID RECEPTORS AND THEIR APPLICATION
NZ736055A (en) Imidazopyrazines and pyrazolopyrimidines and their use as ampa receptor modulators
MX376113B (en) AZABENZIMIDAZOLE DERIVATIVES AS AMPA RECEPTOR MODULATORS, AND THEIR USE IN THE TREATMENT OF DISEASES ASSOCIATED WITH AMPA RECEPTORS.
MX378389B (en) Benzimidazolone and benzothiazolone compounds and their use as ampa receptor modulators
MX379454B (en) FLUOROINDOL DERIVATIVES AS POSITIVE ALLOSTERIC MODULATORS OF THE MUSCARINIC M1 RECEPTOR.
EA201892529A1 (en) COMBINATION OF PURE ANTAGONISTS OF 5-HTRECEPTORS WITH ACETYLHOLINESTERASE INHIBITORS
EA201991045A1 (en) CONDENSED ASAGETEROCYCLIC COMPOUNDS AND THEIR APPLICATION AS AMPA RECEPTOR MODULATORS
MX2022011310A (en) Azabicyclo and diazepine derivatives for treating ocular disorders.
TN2018000175A1 (en) Indane derivatives as mglur7 modulators
CL2017002605A1 (en) Indole derivatives
EA202192092A3 (en) TETRAHYDRO-PYRIDO[3,4-B]INDOL MODULATORS OF ESTROGEN RECEPTORS AND THEIR APPLICATION
MX369806B (en) Indolone compounds and their use as ampa receptor modulators.
AR122456A2 (en) TETRAHYDRO-PYRIDO[3,4-B]INDOLS MODULATORS OF ESTROGEN RECEPTORS AND THEIR USES
EA201991734A1 (en) Estrogen Receptor Modulators